XT
TEVA icon

XTX Topco’s Teva Pharmaceuticals TEVA Stock Holding History

XTX Topco’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.49M Buy
+44,064
New +$1.47M 0.02% 1409
2026
Q1 		– Sell
-35,872
Closed -$1.12M – 4384
2025
Q4 		$1.12M Buy
+35,872
New +$884K 0.03% 951
2025
Q3 		– Sell
-241,692
Closed -$4.05M – 3263
2025
Q2 		$4.05M Buy
241,692
+81,651
+51% +$1.32M 0.17% 111
2025
Q1 		$2.46M Buy
+160,041
New +$2.86M 0.13% 179
2024
Q4 		– Sell
-28,092
Closed -$506K – 2926
2024
Q3 		$506K Sell
28,092
-38,976
-58% -$682K 0.04% 807
2024
Q2 		$1.09M Sell
67,068
-10,459
-13% -$161K 0.09% 327
2024
Q1 		$1.09M Buy
+77,527
New +$977K 0.15% 133
2023
Q2 		– Sell
-27,313
Closed -$242K – 1835
2023
Q1 		$242K Buy
+27,313
New +$270K 0.05% 806
2022
Q4 		– Sell
-15,099
Closed -$122K – 1505
2022
Q3 		$122K Sell
15,099
-16,365
-52% -$145K 0.03% 910
2022
Q2 		$237K Buy
+31,464
New +$274K 0.1% 388
2021
Q3 		– Sell
-41,006
Closed -$406K – 1054
2021
Q2 		$406K Buy
+41,006
New +$434K 0.14% 250

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

XTX Topco's TEVA Position: Q2 2026 in Review

XTX Topco opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 44,064 shares worth $1.49M. The stake represents 0.02% of the portfolio and ranks #1409 among its holdings. This is a return to the name: XTX Topco previously reported a position in TEVA as recently as Q4 2025.

XTX Topco first reported a position in TEVA in Q2 2021 and has held it in 11 quarters since. The position peaked at $4.05M in Q2 2025. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • XTX Topco held 44,064 shares of Teva Pharmaceuticals worth $1.49M as of Q2 2026.
  • Teva Pharmaceuticals was a new XTX Topco position in Q2 2026.
  • Teva Pharmaceuticals made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1409 holding.
  • XTX Topco first reported a position in Teva Pharmaceuticals in Q2 2021 and has held it in 11 quarters since.
  • XTX Topco's Teva Pharmaceuticals position peaked at $4.05M in Q2 2025.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.